|
|
| | Dabrafenib Impurity B Basic information |
| Product Name: | Dabrafenib Impurity B | | Synonyms: | Dabrafenib Impurity B;Benzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,5-difluoro-;N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,5-difluorobenzenesulfonamide;N - {3 - [5 - (2 - amino - 4 - pyrimidine base) - 2 - (1, 1-2 methyl ethyl) - 1, 3 - thiazole - 4 - base] phenyl} - 2 - fluorine - 2, 5 - two fluorine benzene sulfonamide | | CAS: | 1195765-44-6 | | MF: | C23H20F3N5O2S2 | | MW: | 519.57 | | EINECS: | | | Product Categories: | | | Mol File: | 1195765-44-6.mol |  |
| | Dabrafenib Impurity B Chemical Properties |
| Boiling point | 659.335±65.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.444±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 6.669±0.10(predicted) |
| | Dabrafenib Impurity B Usage And Synthesis |
| | Dabrafenib Impurity B Preparation Products And Raw materials |
|